Rosemont Pharmaceuticals
Janice Robottom is a Senior Project Manager at Rosemont Pharmaceuticals since October 2021, previously holding the position of Project Manager. Prior to this role, Janice was with Aptamer Group from February 2019 to September 2021, where Janice advanced from Research and Development Manager to Senior R&D Scientist and then to R&D Scientist. Janice's earlier experience includes working as a Research Scientist at Mologic - BIG in tiny Science from October 2017 to February 2019. Janice began an academic career as a PhD student at the University of Leeds from October 2012 to November 2017, earning a Doctor of Philosophy in Cell/Cellular and Molecular Biology, after completing a Bachelor of Science in Biochemistry at the same institution from 2009 to 2012.
Rosemont Pharmaceuticals
At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines. Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges. At Rosemont we have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. All of our products, both licensed and ‘specials’ are made to the same exacting standards under GMP. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are always seeking to expand our range of medicines and covert our ‘specials’ to licensed product wherever possible.